Health Economic Modelling
We build rigorous cost-effectiveness and budget impact models, integrating real-world data and assumptions to inform reimbursement decisions, payer negotiations, and strategic planning.
Market Access
We help pharmaceutical companies bring their products to the right patients at the right time and right price.
We assist pharmaceutical companies in bringing a new drug to the right patient group promptly and at an optimal price. Our support is always available for Market Access experts, managers, directors, and business units, whether it involves evaluating healthcare interventions, health economic modeling, pricing and reimbursement applications, risk-sharing agreements and models, or market analytics.
What makes our Market Access services unique?
Medaffcon is a full-service provider in Market Access. In our services, we offer strategic and tactical advice and expert services, especially for pharmaceutical companies, covering all phases of market entry and subsequent phases of the product lifecycle.
The goal of Market Access activities is to ensure that new technology, such as a drug, reaches the right patient group as quickly as possible after obtaining marketing authorization at a price that is optimal for healthcare providers, payers, and the marketing authorization holder. This activity aims to mitigate or remove non-medical barriers to the use of technology.
Medaffcon excels in the evaluation of healthcare methods, health economic modeling, pricing and reimbursement applications, interactive tools and calculators, risk-sharing models, and market analysis based on real-life data.
We have carried out dozens of market access projects annually for 15 years, which gives us a broad and insightful expertise. Our active collaboration with authorities, like Fimea, the Pharmaceuticals Pricing Board, and the scientific community ensures that our information is up-to-date and that we can consider the challenges and perspectives of all stakeholders.
Our experts work closely with clients’ Market Access directors, managers, and specialists, as well as business accountables. We provide knowledgeable support, whether it involves the drug pricing and reimbursement application process, strategic market entry planning, or current trends in the pharmaceutical industry.
Read an overview of the Finnish market access and pricing system – This article outlines how healthcare is organized, how decisions are made, and which public bodies are involved, providing clear background context for companies seeking to familiarize themselves with Finland’s regulatory and reimbursement environment.
Our Market Access services
-
-
Pricing and Reimbursement
We guide you through the full reimbursement journey — strategic counsel, dossier crafting, submission, defense, and linkage to evidence generation to secure access under optimal conditions.
-
Interactive value tools
We transform complex clinical, economic, and utilization data into intuitive, stakeholder-facing tools (dashboards, calculators) to support internal decisions, payer dialogue, and external communication.
-
Patient Dynamics
We deliver a reporting tool tracking patient flows and reimbursement data for outpatient medications, enabling sales, marketing, and management to monitor brand performance and market trends.
-
Risk-Sharing Agreements
We design and negotiate performance-based or conditional reimbursement contracts, structuring pricing, evaluation metrics, and risk allocation to accelerate access and balance stakeholder interests.
-
Expert Resourcing
We supply experienced interim professionals to fill gaps in medical or market access teams, manage deliverables, and ensure continuity during organizational transitions.
Medaffcon as Your Market Access partner
Local Expertise and Experience
We have deep understanding of local operating environments and national requirements, enabling us to navigate complexities efficiently and support a seamless market access journey from start to finish.
Expert Solutions
We provide knowledgeable guidance and take a proactive, solution-oriented approach, supporting every phase of market access projects with practical expertise and consistent focus on achieving results.
Reliability
We act with integrity and dependability, setting clear expectations and delivering on them while addressing key challenges promptly and advocating for our clients without unnecessary effort or delays.
Contact us!
Related articles
-
Outsourcing Renewal Applications Frees Up Internal Resources
Medaffcon prepares around 25–30 renewal applications each year for approximately 10–15 clients. The volume ensures well-established routines and consistently high quality.
-
A Valuable Drug Portfolio May Remain Underutilised
Pharmaceutical companies’ product portfolios are valuable assets, yet they may remain underutilised. How to unlock the full potential of a drug portfolio?
-
Trump’s MFN Drug Pricing Policy Is Reshaping Pharmaceutical Markets
The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.
